Windtree Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Windtree Therapeutics
WINT Stock  USD 1.80  0.12  6.25%   
Windtree Therapeutics financial statements provide useful quarterly and yearly information to potential Windtree Therapeutics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Windtree Therapeutics financial statements helps investors assess Windtree Therapeutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Windtree Therapeutics' valuation are summarized below:
Gross Profit
-17.8 M
Market Capitalization
4.9 M
Enterprise Value Revenue
706.0804
Earnings Share
(19.03)
Quarterly Revenue Growth
(1.00)
There are currently one hundred twenty fundamental gauges for Windtree Therapeutics that can be evaluated and compared over time across peers. All traders should confirm Windtree Therapeutics' prevalent fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to drop to about 963.5 M in 2025. Enterprise Value is likely to drop to about 951.8 M in 2025

Windtree Therapeutics Total Revenue

0.0

Check Windtree Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Windtree Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 89.6 K, Interest Expense of 54.6 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 1.9 K, Dividend Yield of 0.0 or PTB Ratio of 2.67. Windtree financial statements analysis is a perfect complement when working with Windtree Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Windtree Therapeutics Correlation against competitors.
For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.

Windtree Therapeutics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets42.3 M37.3 M51.1 M
Pretty Stable
Short and Long Term Debt Total9.8 M19.4 M12.8 M
Pretty Stable
Other Current Liabilities3 M2.9 M5.5 M
Slightly volatile
Total Current Liabilities8.4 M4.6 M8.6 M
Pretty Stable
Accounts Payable691.7 K728.1 K1.4 M
Pretty Stable
Common Stock Shares Outstanding265.6 K253 K68.4 K
Slightly volatile
Liabilities And Stockholders Equity42.3 M37.3 M51.1 M
Pretty Stable
Non Current Liabilities Total30.2 M28.8 M21.8 M
Slightly volatile
Other Stockholder Equity1 B975.4 M660 M
Slightly volatile
Total Liabilities21.5 M33.4 M29.3 M
Slightly volatile
Total Current Assets5.9 M6.2 M21.3 M
Slightly volatile
Short Term Debt730.9 K769.4 K3.5 M
Very volatile
Property Plant And Equipment Net2.5 M1.9 M1.7 M
Slightly volatile
Cash4.7 M5 M19.2 M
Slightly volatile
Non Current Assets Total18 M31.1 M28.6 M
Slightly volatile
Cash And Short Term Investments4.7 M5 M20.1 M
Slightly volatile
Common Stock Total Equity14.5 K15.3 K709.1 K
Slightly volatile
Other Current Assets956.1 K954 K1.2 M
Pretty Stable
Property Plant And Equipment Gross6.5 M6.2 M2.4 M
Slightly volatile
Common Stock5.1 K5.4 K706.3 K
Slightly volatile
Non Currrent Assets Other163.9 K172.5 K444.9 K
Pretty Stable
Inventory23.1 K24.3 K87.1 K
Slightly volatile
Other Liabilities13.2 M12.6 M7.1 M
Slightly volatile
Long Term Debt2.6 M2.8 M8.7 M
Pretty Stable
Property Plant Equipment2.1 M3.1 M1.9 M
Slightly volatile
Net Receivables94.2 K89.7 K72.9 K
Slightly volatile
Long Term Debt Total2.6 M2.8 M9.6 M
Pretty Stable
Capital Surpluse662.9 M908.8 M648.2 M
Slightly volatile
Short and Long Term Debt199.2 K209.7 K9.3 M
Slightly volatile
Non Current Liabilities Other16.4 M21.6 M9.9 M
Slightly volatile
Deferred Long Term Liabilities12.1 M19.3 M8.3 M
Slightly volatile
Intangible Assets41.8 M22.7 M62.2 M
Slightly volatile
Capital Lease Obligations1.9 M1.8 M1.7 M
Slightly volatile

Windtree Therapeutics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization89.6 K94.3 K640.9 K
Slightly volatile
Interest Expense54.6 K57.5 K1.1 M
Slightly volatile
Other Operating Expenses29 M20.2 M28.5 M
Pretty Stable
Total Operating Expenses28.8 M20.1 M28.2 M
Pretty Stable
Selling General Administrative9.5 K10 K9.2 M
Slightly volatile
Research Development18.7 M9.5 M17.3 M
Pretty Stable
Interest Income406.5 K292.5 K1.5 M
Slightly volatile
Preferred Stock And Other Adjustments5.1 M5.7 M6.3 M
Slightly volatile
Reconciled Depreciation89.6 K94.3 K190.4 K
Very volatile
Selling And Marketing Expenses7.4 M8.3 M9 M
Slightly volatile

Windtree Therapeutics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow6.9 M7.3 M19.9 M
Pretty Stable
Depreciation89.6 K94.3 K436.1 K
Slightly volatile
Total Cash From Financing Activities26.4 M13.3 M24.4 M
Pretty Stable
End Period Cash Flow4.9 M5.1 M19.3 M
Slightly volatile
Other Cashflows From Investing Activities229242989.5 K
Very volatile
Stock Based Compensation1.1 M1.2 M81.8 M
Slightly volatile
Exchange Rate Changes308 K542.8 K250.2 K
Slightly volatile
Issuance Of Capital Stock16.6 M10.4 M25.9 M
Slightly volatile
Dividends Paid121136148
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.9 K2 K4.2 K
Slightly volatile
Stock Based Compensation To Revenue37.0839.0482.8068
Slightly volatile
Capex To Depreciation0.20.210.7141
Pretty Stable
EV To Sales1.8 K1.9 K4.1 K
Slightly volatile
Sales General And Administrative To Revenue75.6572.0431.3532
Slightly volatile
Research And Ddevelopement To Revenue60.5557.6745.8437
Slightly volatile
Capex To Revenue0.90.870.8726
Very volatile
Cash Per Share21.4522.5851.3 K
Slightly volatile
Income Quality0.90.760.806
Slightly volatile
Intangibles To Total Assets0.840.90.7811
Pretty Stable
Current Ratio1.471.553.3529
Slightly volatile
Capex Per Share0.07450.07842.2 K
Slightly volatile
Revenue Per Share21.6322.771.3 K
Slightly volatile
Interest Debt Per Share83.8288.243.6 K
Slightly volatile
Debt To Assets0.330.470.6219
Very volatile
Ebt Per Ebit0.821.041.0328
Very volatile
Quick Ratio1.471.553.351
Slightly volatile
Net Income Per E B T1.131.111.0608
Slightly volatile
Cash Ratio1.181.242.3552
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.131.151.0281
Slightly volatile
Fixed Asset Turnover0.09890.10.8299
Slightly volatile
Debt Ratio0.330.470.6219
Very volatile
Price Sales Ratio1.9 K2 K4.2 K
Slightly volatile
Asset Turnover0.00140.00150.0526
Pretty Stable

Windtree Therapeutics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap963.5 M1 B2 B
Slightly volatile
Enterprise Value951.8 M1 B2 B
Slightly volatile

Windtree Fundamental Market Drivers

Forward Price Earnings0.3652
Cash And Short Term Investments4.3 M

Windtree Upcoming Events

1st of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
1st of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Windtree Therapeutics Financial Statements

Windtree Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Windtree Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Windtree Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Windtree Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue178.2 K169.3 K
Cost Of Revenue73.8 K70.1 K
Stock Based Compensation To Revenue 39.04  37.08 
Sales General And Administrative To Revenue 72.04  75.65 
Research And Ddevelopement To Revenue 57.67  60.55 
Capex To Revenue 0.87  0.90 
Revenue Per Share 22.77  21.63 
Ebit Per Revenue(144.58)(137.35)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Windtree Stock Analysis

When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY